Cargando…
Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens
Mutations in emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages can interfere with laboratory methods used to generate viral genome sequences for public health surveillance. We identified 20 mutations that are widespread in variant of concern lineages and affect widely us...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555373/ https://www.ncbi.nlm.nih.gov/pubmed/34757201 http://dx.doi.org/10.1016/j.ijid.2021.10.050 |
_version_ | 1784591965366517760 |
---|---|
author | Kuchinski, Kevin S. Nguyen, Jason Lee, Tracy D. Hickman, Rebecca Jassem, Agatha N. Hoang, Linda M.N. Prystajecky, Natalie A. Tyson, John R. |
author_facet | Kuchinski, Kevin S. Nguyen, Jason Lee, Tracy D. Hickman, Rebecca Jassem, Agatha N. Hoang, Linda M.N. Prystajecky, Natalie A. Tyson, John R. |
author_sort | Kuchinski, Kevin S. |
collection | PubMed |
description | Mutations in emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages can interfere with laboratory methods used to generate viral genome sequences for public health surveillance. We identified 20 mutations that are widespread in variant of concern lineages and affect widely used sequencing protocols by the ARTIC network and Freed et al. Three of these mutations disrupted sequencing of P.1 lineage specimens during a recent outbreak in British Columbia, Canada. We provide laboratory validation of protocol modifications that restored sequencing performance. The study findings indicate that genomic sequencing protocols require immediate updating to address emerging mutations. This work also suggests that routine monitoring and protocol updates will be necessary as SARS-CoV-2 continues to evolve. The bioinformatic and laboratory approaches used here provide guidance for this kind of assay maintenance. |
format | Online Article Text |
id | pubmed-8555373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85553732021-10-29 Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens Kuchinski, Kevin S. Nguyen, Jason Lee, Tracy D. Hickman, Rebecca Jassem, Agatha N. Hoang, Linda M.N. Prystajecky, Natalie A. Tyson, John R. Int J Infect Dis Short Communication Mutations in emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages can interfere with laboratory methods used to generate viral genome sequences for public health surveillance. We identified 20 mutations that are widespread in variant of concern lineages and affect widely used sequencing protocols by the ARTIC network and Freed et al. Three of these mutations disrupted sequencing of P.1 lineage specimens during a recent outbreak in British Columbia, Canada. We provide laboratory validation of protocol modifications that restored sequencing performance. The study findings indicate that genomic sequencing protocols require immediate updating to address emerging mutations. This work also suggests that routine monitoring and protocol updates will be necessary as SARS-CoV-2 continues to evolve. The bioinformatic and laboratory approaches used here provide guidance for this kind of assay maintenance. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-01 2021-10-29 /pmc/articles/PMC8555373/ /pubmed/34757201 http://dx.doi.org/10.1016/j.ijid.2021.10.050 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Kuchinski, Kevin S. Nguyen, Jason Lee, Tracy D. Hickman, Rebecca Jassem, Agatha N. Hoang, Linda M.N. Prystajecky, Natalie A. Tyson, John R. Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens |
title | Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens |
title_full | Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens |
title_fullStr | Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens |
title_full_unstemmed | Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens |
title_short | Mutations in emerging variant of concern lineages disrupt genomic sequencing of SARS-CoV-2 clinical specimens |
title_sort | mutations in emerging variant of concern lineages disrupt genomic sequencing of sars-cov-2 clinical specimens |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555373/ https://www.ncbi.nlm.nih.gov/pubmed/34757201 http://dx.doi.org/10.1016/j.ijid.2021.10.050 |
work_keys_str_mv | AT kuchinskikevins mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens AT nguyenjason mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens AT leetracyd mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens AT hickmanrebecca mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens AT jassemagathan mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens AT hoanglindamn mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens AT prystajeckynataliea mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens AT tysonjohnr mutationsinemergingvariantofconcernlineagesdisruptgenomicsequencingofsarscov2clinicalspecimens |